Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 10, 2020

SELL
$105.46 - $144.13 $215,665 - $294,745
-2,045 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$87.74 - $152.74 $9,124 - $15,884
104 Added 5.36%
2,045 $204,000
Q4 2019

Feb 14, 2020

BUY
$117.65 - $153.73 $16,823 - $21,983
143 Added 7.95%
1,941 $290,000
Q3 2019

Nov 14, 2019

BUY
$125.18 - $143.24 $21,155 - $24,207
169 Added 10.37%
1,798 $230,000
Q1 2019

May 16, 2019

BUY
$121.81 - $142.95 $198,428 - $232,865
1,629 New
1,629 $233,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.8B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Covenant Partners, LLC Portfolio

Follow Covenant Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covenant Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Covenant Partners, LLC with notifications on news.